This bid is closed — responses were due May 4, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This is a funding opportunity (grant) for innovative research in cancer nanotechnology. Clinical trials are not allowed under this funding opportunity. The funding opportunity number is PAR-25-106 and the CFDA numbers are 93.394 and 93.395.
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds contracting-officer contacts and AI response outlines.